SCHEMBL147953

SCHEMBL147953

CCNC(=O)c1cc2c(Br)cccc2[nH]1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.52
ALOX15 P16050 1/20 0.50
FLT3 P36888 1/20 0.50
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23836114 0.84 GRIN2D (0.56) ALOX15NPC1POLBRAB9AGRIN2D
SCHEMBL24740807 0.84 FLT3 (0.51) ALOX15FLT3NPC1POLBRAB9A
SCHEMBL31414534 0.84 HRH4 (0.56) HRH4ALOX15FLT3NPC1POLB
SCHEMBL25768284 0.83 ALOX15 (0.57) HRH4ALOX15FLT3NPC1POLB
SCHEMBL24448134 0.81 POLB (0.70) HRH4FLT3NPC1POLBRAB9A
SCHEMBL25852999 0.80 HDAC3 (0.58) ALOX15FLT3NPC1POLBRAB9A
SCHEMBL25812301 0.80 ALOX15 (0.47) ALOX15NPC1POLBRAB9AGRIN2D
SCHEMBL31439894 0.79 NPC1 (0.47) HRH4FLT3NPC1POLBRAB9A
SCHEMBL2205092 0.78 HRH4 (0.56) HRH4FLT3KDM4EMEN1KMT2A
SCHEMBL25768183 0.78 POLB (0.54) ALOX15FLT3NPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391602-B1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-12-04 EP disclosed
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 HRH4 1241/4885ALOX15 4154/4885FLT3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.